Dietary indoles suppress delayed-type hypersensitivity by inducing a switch from proinflammatory Th17 cells to anti-inflammatory regulatory T cells through regulation of MicroRNA

Journal of Immunology

Volumn 196, Issue 3, 2016, Pages 1108-1122

  Singh, Narendra P ^a   Singh, Udai P ^a   Rouse, Michael ^a   Zhang, Jiajia ^b   Chatterjee, Saurabh ^b   Nagarkatti, Prakash S ^a   Nagarkatti, Mitzi ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; 3,3' DIINDOLYLMETHANE; INTERLEUKIN 10; INTERLEUKIN 17; MICRORNA; MICRORNA 1192; MICRORNA 219; MICRORNA 490; MICRORNA 495; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; 1,1-BIS(3'-INDOLYL)METHANE; 6-FORMYLINDOLO(3,2-B)CARBAZOLE; AROMATIC HYDROCARBON RECEPTOR; CARBAZOLE DERIVATIVE; INDOLE DERIVATIVE; LIGAND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DRUG MECHANISM; FEMALE; INTERLEUKIN 17 GENE; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; TH17 CELL; TRANSCRIPTION FACTOR FOXP3 GENE; WILD TYPE; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CELL DIFFERENTIATION; DIET; DISEASE MODEL; DRUG EFFECTS; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; CARBAZOLES; CELL DIFFERENTIATION; DIET; DISEASE MODELS, ANIMAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; HYPERSENSITIVITY, DELAYED; INDOLES; LIGANDS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, ARYL HYDROCARBON; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84957625583     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1501727     Document Type: Article

References (69)

1. Verhoeven, D. T., H. Verhagen, R. A. Goldbohm, P. A. van den Brandt, and G. van Poppel. 1997. A review of mechanisms underlying anticarcinogenicity by brassica vegetables. Chem. Biol. Interact. 103: 79-129.
2. Takahashi, N., R. H. Dashwood, L. F. Bjeldanes, D. E. Williams, and G. S. Bailey. 1995. Mechanisms of indole-3-carbinol (I3C) anticarcinogenesis: inhibition of aflatoxin B1-DNA adduction and mutagenesis by I3C acid con-densation products. Food Chem. Toxicol. 33: 851-857.
3. Singh, U. P., A. E. Murphy, R. T. Enos, H. A. Shamran, N. P. Singh, H. Guan, V. L. Hegde, D. Fan, R. L. Price, D. D. Taub, et al. 2014. miR-155 deficiency protects mice from experimental colitis by reducing T helper type 1/type 17 responses. Immunology 143: 478-489.
4. Ribaux, P., O. Irion, and M. Cohen. 2012. An active product of cruciferous vegetables, 3, 39-diindolylmethane, inhibits invasive properties of extravillous cytotrophoblastic cells. Neuroendocrinol. Lett. 33: 133-137.
5. Taylor-Harding, B., H. Agadjanian, H. Nassanian, S. Kwon, X. Guo, C. Miller, B. Y. Karlan, S. Orsulic, and C. S. Walsh. 2012. Indole-3-carbinol synergistically sensitises ovarian cancer cells to bortezomib treatment. Br. J. Cancer 106: 333-343.
6. Baur, J. A., K. J. Pearson, N. L. Price, H. A. Jamieson, C. Lerin, A. Kalra, V. V. Prabhu, J. S. Allard, G. Lopez-Lluch, K. Lewis, et al. 2006. Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444: 337-342.
7. Chen, T., Z. Li, T. Jing, W. Zhu, J. Ge, X. Zheng, X. Pan, H. Yan, and J. Zhu. 2011. MicroRNA-146a regulates the maturation process and pro-inflammatory cytokine secretion by targeting CD40L in oxLDL-stimulated dendritic cells. FEBS Lett. 585: 567-573.
8. Armour, S. M., J. A. Baur, S. N. Hsieh, A. Land-Bracha, S. M. Thomas, and D. A. Sinclair. 2009. Inhibition of mammalian S6 kinase by resveratrol suppresses autophagy. Aging (Albany, N.Y.) 1: 515-528.
9. Higdon, J. V., B. Delage, D. E. Williams, and R. H. Dashwood. 2007. Cruciferous vegetables and human cancer risk: epidemiologic evidence and mechanistic basis. Pharmacol. Res. 55: 224-236.
10. Tang, L., G. R. Zirpoli, K. Guru, K. B. Moysich, Y. Zhang, C. B. Ambrosone, and S. E. McCann. 2008. Consumption of raw cruciferous vegetables is inversely associated with bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 17: 938-944.
11. Juge, N., R. F. Mithen, and M. Traka. 2007. Molecular basis for chemo-prevention by sulforaphane: a comprehensive review. Cell. Mol. Life Sci. 64: 1105-1127.
12. Nishino, H., M. Murakoshi, X. Y. Mou, S. Wada, M. Masuda, Y. Ohsaka, Y. Satomi, and K. Jinno. 2005. Cancer prevention by phytochemicals. Oncology 69(Suppl. 1): 38-40.
13. Brandi, G., A. Fraternale, S. Lucarini, M. Paiardini, M. De Santi, B. Cervasi, M. F. Paoletti, L. Galluzzi, A. Duranti, and M. Magnani. 2013. Antitumoral activity of indole-3-carbinol cyclic tri - And tetrameric derivatives mixture in human breast cancer cells: in vitro and in vivo studies. Anticancer. Agents Med. Chem. 13: 654-662.
14. Aggarwal, B. B., and H. Ichikawa. 2005. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 4: 1201-1215.
15. Marconett, C. N., A. K. Singhal, S. N. Sundar, and G. L. Firestone. 2012. Indole-3-carbinol disrupts estrogen receptor - A dependent expression of insulin-like growth factor-1 receptor and insulin receptor substrate-1 and proliferation of human breast cancer cells. Mol. Cell. Endocrinol. 363: 74-84.
16. Inomata, M., H. Tagawa, Y. M. Guo, Y. Kameoka, N. Takahashi, and K. Sawada. 2009. MicroRNA-17-92 down-regulates expression of distinct targets in different B-cell lymphoma subtypes. Blood 113: 396-402.
17. Shimamoto, K., H. Hayashi, E. Taniai, R. Morita, M. Imaoka, Y. Ishii, K. Suzuki, M. Shibutani, and K. Mitsumori. 2011. Antioxidant N - Acetyl-L-cysteine (NAC) supplementation reduces reactive oxygen species (ROS)-mediated hepatocellular tumor promotion of indole-3-carbinol (I3C) in rats. J. Toxicol. Sci. 36: 775-786.
18. 1 arrest and apoptosis in human acute T-cell lymphoblastic leukemia cells. PLoS One 7: e34975.
19. Singh-Gupta, V., S. Banerjee, C. K. Yunker, J. T. Rakowski, M. C. Joiner, A. A. Konski, F. H. Sarkar, and G. G. Hillman. 2012. B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer. Cancer Lett. 318: 86-92.
20. 2/M arrest and apoptosis in oral squamous cell carcinoma by modulating Akt-NF-kB, MAPK, and p53 signaling. Chem. Biol. Interact. 195: 224-230.
21. Hu, J., H. Chang, L. Wang, S. Wu, B. Shao, J. Zhou, and Y. Zhao. 2008. Detection, occurrence and fate of indirubin in municipal sewage treatment plants. Environ. Sci. Technol. 42: 8339-8344.
22. Song, J., M. Clagett-Dame, R. E. Peterson, M. E. Hahn, W. M. Westler, R. R. Sicinski, and H. F. DeLuca. 2002. A ligand for the aryl hydrocarbon receptor isolated from lung. Proc. Natl. Acad. Sci. USA 99: 14694-14699.
23. Tian, Y., S. Ke, M. S. Denison, A. B. Rabson, and M. A. Gallo. 1999. Ah receptor and NF-kB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274: 510-515.
24. Denison, M. S., and S. Heath-Pagliuso. 1998. The Ah receptor: a regulator of the biochemical and toxicological actions of structurally diverse chemicals. Bull. Environ. Contam. Toxicol. 61: 557-568.
25. Denison, M. S., A. Pandini, S. R. Nagy, E. P. Baldwin, and L. Bonati. 2002. Ligand binding and activation of the Ah receptor. Chem. Biol. Interact. 141: 3-24.
26. Dertinger, S. D., D. A. Nazarenko, A. E. Silverstone, and T. A. Gasiewicz. 2001. Aryl hydrocarbon receptor signaling plays a significant role in mediating benzo [a]pyrene - And cigarette smoke condensate-induced cytogenetic damage in vivo. Carcinogenesis 22: 171-177.
27. 1-450 gene. J. Cell. Biochem. 35: 153-160.
28. Bock, K. W., and C. Köhle. 2006. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem. Pharmacol. 72: 393-404.
29. Esser, C., A. Rannug, and B. Stockinger. 2009. The aryl hydrocarbon receptor in immunity. Trends Immunol. 30: 447-454.
30. Stevens, E. A., J. D. Mezrich, and C. A. Bradfield. 2009. The aryl hydrocarbon receptor: a perspective on potential roles in the immune system. Immunology 127: 299-311.
31. + cells with characteristics of regulatory T cells. J. Immunol. 175: 4184-4188.
32. Veldhoen, M., K. Hirota, J. Christensen, A. O'Garra, and B. Stockinger. 2009. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J. Exp. Med. 206: 43-49.
33. Singh, N. P., U. P. Singh, B. Singh, R. L. Price, M. Nagarkatti, and P. S. Nagarkatti. 2011. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One 6: e23522.
34. + regulatory T cells by TGF-b induction of transcription factor Foxp3. J. Exp. Med. 198: 1875-1886.
35. H17 cell differentiation by the aryl hydrocarbon receptor. Nature 453: 65-71.
36. Nakahama, T., H. Hanieh, N. T. Nguyen, I. Chinen, B. Ripley, D. Millrine, S. Lee, K. K. Nyati, P. K. Dubey, K. Chowdhury, et al. 2013. Aryl hydrocarbon receptor-mediatedinduction of the microRNA-132/212 cluster promotes interleukin-17-producing T-helper cell differentiation. Proc. Natl. Acad. Sci. USA 110: 11964-11969. doi:10.1073/pnas.1311087110
37. Ishii, A., K. Oboki, A. Nambu, H. Morita, T. Ohno, N. Kajiwara, K. Arae, H. Sudo, K. Okumura, H. Saito, and S. Nakae. 2010. Development of IL-17-mediated delayed-type hypersensitivity is not affected by down-regulation of IL-25 expression. Allergol. Int. 59: 399-408.
38. Bartel, D. P. 2004. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
39. Bertelli, A. A., R. Baccalini, E. Battaglia, M. Falchi, and M. E. Ferrero. 2001. Resveratrol inhibits TNFa-induced endothelial cell activation. Therapie 56: 613-616.
40. Grimm, D., K. L. Streetz, C. L. Jopling, T. A. Storm, K. Pandey, C. R. Davis, P. Marion, F. Salazar, and M. A. Kay. 2006. Fatality in mice due to oversatu-ration of cellular microRNA/short hairpin RNA pathways. Nature 441: 537-541.
41. Iorio, M. V., and C. M. Croce. 2009. MicroRNAs in cancer: small molecules with a huge impact. J. Clin. Oncol. 27: 5848-5856.
42. + T cells by the microRNA miR-125b. Nat. Immunol. 12: 796-803.
43. Smigielska-Czepiel, K., A. van den Berg, P. Jellema, R. J. van der Lei, J. Bijzet, J. Kluiver, A. M. Boots, E. Brouwer, and B. J. Kroesen. 2014. Comprehensive analysis of miRNA expression in T-cell subsets of rheumatoid arthritis patients reveals defined signatures of naive and memory Tregs. Genes Immun. 15: 115-125.
44. Ma, X., J. Zhou, Y. Zhong, L. Jiang, P. Mu, Y. Li, N. Singh, M. Nagarkatti, and P. Nagarkatti. 2014. Expression, regulation and function of microRNAs in multiple sclerosis. Int. J. Med. Sci. 11: 810-818.
45. Rao, R., P. Nagarkatti, and M. Nagarkatti. 2015. Role of miRNA in the regulation of inflammatory genes in staphylococcal enterotoxin B-induced acute inflammatory lung injury and mortality. Toxicol. Sci. 144: 284-297.
46. Rouse, M., R. Rao, M. Nagarkatti, and P. S. Nagarkatti. 2014. 3, 39-Diindolyl-methane ameliorates experimental autoimmune encephalomyelitis by promoting cell cycle arrest and apoptosis in activated T cells through microRNA signaling pathways. J. Pharmacol. Exp. Ther. 350: 341-352.
47. Zhou, J., P. Nagarkatti, Y. Zhong, J. P. Ginsberg, N. P. Singh, J. Zhang, and M. Nagarkatti. 2014. Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder. PLoS One 9: e94075.
48. Hegde, V. L., S. Tomar, A. Jackson, R. Rao, X. Yang, U. P. Singh, N. P. Singh, P. S. Nagarkatti, and M. Nagarkatti. 2013. Distinct microRNA expression profile and targeted biological pathways in functional myeloid-derived suppressor cells induced by D9-tetrahydrocannabinol in vivo: regulation of CCAAT/enhancer-binding protein a by microRNA-690. J. Biol. Chem. 288: 36810-36826.
49. Nakae, S., Y. Komiyama, A. Nambu, K. Sudo, M. Iwase, I. Homma, K. Sekikawa, M. Asano, and Y. Iwakura. 2002. Antigen-specific T cell sensiti-zation is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17: 375-387.
50. Komiyama, Y., S. Nakae, T. Matsuki, A. Nambu, H. Ishigame, S. Kakuta, K. Sudo, and Y. Iwakura. 2006. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J. Immunol. 177: 566-573.
51. Ishigame, H., S. Kakuta, T. Nagai, M. Kadoki, A. Nambu, Y. Komiyama, N. Fujikado, Y. Tanahashi, A. Akitsu, H. Kotaki, et al. 2009. Differential roles of interleukin-17A and-17F in host defense against mucoepithelial bacterial infection and allergic responses. Immunity 30: 108-119.
52. Rouse, M., N. P. Singh, P. S. Nagarkatti, and M. Nagarkatti. 2013. Indoles mitigate the development of experimental autoimmune encephalomyelitis by induction of reciprocal differentiation of regulatory T cells and Th17 cells. Br. J. Pharmacol. 169: 1305-1321.
53. Singh, N. P., V. L. Hegde, L. J. Hofseth, M. Nagarkatti, and P. Nagarkatti. 2007. Resveratrol (trans-3, 5, 49-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis, primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol. Pharmacol. 72: 1508-1521.
54. Akahira-Azuma, M., M. Szczepanik, R. F. Tsuji, R. A. Campos, A. Itakura, N. Mobini, J. McNiff, I. Kawikova, B. Lu, C. Gerard, et al. 2004. Early delayed-type hypersensitivity eosinophil infiltrates depend on T helper 2 cytokines and interferon-g via CXCR3 chemokines. Immunology 111: 306-317.
55. Singh, N. P., I. K. Abbas, M. Menard, U. P. Singh, J. Zhang, P. Nagarkatti, and M. Nagarkatti. 2015. Exposure to diethylstilbestrol during pregnancy modulates microRNA expression profile in mothers and fetuses reflecting oncogenic and immunological changes. Mol. Pharmacol. 87: 842-854.
56. Wenzel, E., T. Soldo, H. Erbersdobler, and V. Somoza. 2005. Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats. Mol. Nutr. Food Res. 49: 482-494.
57. Zhong, M. C., N. Kerlero de Rosbo, and A. Ben-Nun. 2002. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. J. Clin. Invest. 110: 81-90.
58. Khwaja, F. S., S. Wynne, I. Posey, and D. Djakiew. 2009. 3, 39-Diindolylmethane induction of p75NTR-dependent cell death via the p38 mitogen - Activated protein kinase pathway in prostate cancer cells. Cancer Prev. Res. (Phila.) 2: 566-571.
59. Coombes, J. L., N. J. Robinson, K. J. Maloy, H. H. Uhlig, and F. Powrie. 2005. Regulatory T cells and intestinal homeostasis. Immunol. Rev. 204: 184-194.
60. Nachshon-Kedmi, M., S. Yannai, A. Haj, and F. A. Fares. 2003. Indole-3-carbinol and 3, 39-diindolylmethane induce apoptosis in human prostate cancer cells. Food Chem. Toxicol. 41: 745-752.
61. Adachi, J., Y. Mori, S. Matsui, H. Takigami, J. Fujino, H. Kitagawa, C. A. Miller, III, T. Kato, K. Saeki, and T. Matsuda. 2001. Indirubin and indigo are potent aryl hydrocarbon receptor ligands present in human urine. J. Biol. Chem. 276: 31475-31478.
62. Knockaert, M., M. Blondel, S. Bach, M. Leost, C. Elbi, G. L. Hager, S. R. Nagy, D. Han, M. Denison, M. Ffrench, et al. 2004. Independent actions on cyclin-dependent kinases and aryl hydrocarbon receptor mediate the antiproliferative effects of indirubins. Oncogene 23: 4400-4412.
63. Busbee, P. B., M. Nagarkatti, and P. S. Nagarkatti. 2014. Natural indoles, indole-3-carbinol and 3, 39-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression. Toxicol. Appl. Pharmacol. 274: 7-16.
64. Okino, S. T., D. Pookot, S. Basak, and R. Dahiya. 2009. Toxic and chemo-preventive ligands preferentially activate distinct aryl hydrocarbon receptor pathways: implications for cancer prevention. Cancer Prev. Res. (Phila.) 2: 251-256.
65. Fisher, M. T., M. Nagarkatti, and P. S. Nagarkatti. 2004. Combined screening of thymocytes using apoptosis-specific cDNA array and promoter analysis yields novel gene targets mediating TCDD-induced toxicity. Toxicol. Sci. 78: 116-124.
66. Pryputniewicz, S. J., M. Nagarkatti, and P. S. Nagarkatti. 1998. Differential induction of apoptosis in activated and resting T cells by 2, 3, 7, 8-tetra-chlorodibenzo-p-dioxin (TCDD) and its repercussion on T cell responsiveness. Toxicology 129: 211-226.
67. Singh, N. P., M. Nagarkatti, and P. Nagarkatti. 2008. Primary peripheral T cells become susceptible to 2, 3, 7, 8-tetrachlorodibenzo-p-dioxin-mediated apoptosis in vitro upon activation and in the presence of dendritic cells. Mol. Pharmacol. 73: 1722-1735.
68. Julliard, W., J. H. Fechner, and J. D. Mezrich. 2014. The aryl hydrocarbon receptor meets immunology: friend or foe? A little of both. Front. Immunol. 5: 458.
69. Duarte, J. H., P. Di Meglio, K. Hirota, H. Ahlfors, and B. Stockinger. 2013. Differential influences of the aryl hydrocarbon receptor on Th17 mediated responses in vitro and in vivo. PLoS One 8: e79819.